Gynecologic Oncology Group Trials

The Gynecologic Oncology Group (GOG) is a non-profit organization with the purpose of promoting excellence in the quality and integrity of clinical and basic scientific research in the field of gynecologic malignancies. The Group is committed to maintaining the highest standards in clinical trials development, execution, analysis and distribution of results. Continuous evaluation of its processes is utilized in order to constantly improve the quality of patient care. To promote this mission, the GOG receives support from the National Cancer Institute (NCI) of the National Institutes for Health (NIH).

Approximately 45 individual clinical trials are active at any one time within GOG for patients with a variety of gynecologic malignancies, including cancers that arise from the ovaries, uterus, cervix, vagina, and vulva. GOG partners with the Foundation for Women’s Cancer to promote clinical trials participation and provide easy-to-access information about clinical trials that currently are open for enrollment.

View the list of GOG Clinical Trials.

Additional Clinical Trial Resources

Spotlight

Women Magazine released a special report on ovarian cancer, featuring Q&A’s with three expert SGO surgeons and important facts about the disease.

Awareness

This year’s GCAM awareness is focused on the important link between obesity and endometrial cancer. Check out the new toolkit to learn more.

Research

The Foundation for Women’s Cancer is pleased to share its 2014-2015 Research Grants and Awards booklet. The booklet describes the prizes and the application process. Prize applications are due on October 8, 2014.

Education

The Gynecologic Cancer Global Health Forum will be Saturday, Sept. 6, 2014 in D.C.. For more information on educational events and courses, click here.